Wednesday, January 03, 2018 2:58:07 PM
If you read the most recent quarterly (and I would suggest you do), you'll see all the convertible notes and their due dates. These notes have resulted in millions of shares of dilution. The lower the price went, the more shares that were needed to be converted.
The Authorized share on the OTC Markets page was last updated November 7, 2017
The Outstanding Shares on the OTC Markets page was last updated November 14, 2017
The Float on the OTC Markets page was last updated November 7, 2017
Much has happened within those two months. The previous reverse split was CANCELLED. A shareholders meeting was held with a vote to increase the AS to 1 billion from 500 million for strategic acquisitions (nothing has been said of that meeting, however I assume the vote passed and GRCK's AS is now 1 billion).
The positives I see going forward are that the notes I mentioned seem to have been tapering off, and I believe within the month they'll be finished. Additionally, they launched CBD.co earlier than anticipated. They had previous revenues from Eqova. And most importantly, they're in a space that is virtually untapped.
All we need is some decent buying pressure and this can easily run into the dimes (keep in mind that management has incentive to make this succeed, as their warrants are at $0.25)
Recent HYEX News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:22:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/24/2023 06:25:27 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/06/2023 06:09:39 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/14/2023 05:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 06:30:40 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/05/2023 08:24:27 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/24/2023 08:12:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 05:30:59 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM